ArticleBioconjugate chemistry2023

Antibody-Proteolysis Targeting Chimera Conjugate Enables Selective Degradation of Receptor-Interacting Serine/Threonine-Protein Kinase 2 in HER2+ Cell Lines.

Karina Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.